Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Nuclear Medicine Seminars is Scopus-indexed (Q4, CiteScore 0.2). Published by Galenos Publishing House.
Checked against the index lists dated .
ISSN 2149-6447Verify ISSN ↗
Publisher: Galenos Publishing House
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Radiology, Nuclear Medicine and Imaging | 346 / 361 | 4th | Q4 |
Not listed in: Web of Science, DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2020–present, best quartile Q4, CiteScore 0.2.
Nuclear Medicine Seminars is Q4 in Radiology, Nuclear Medicine and Imaging (rank 346 of 361), by CiteScore 2025.
Nuclear Medicine Seminars is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 0.2, quartile Q4, 4th percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.133, quartile Q4, with an H-index of 3.
Nuclear Medicine Seminars is published by Galenos Publishing House. Its ISSN is 2149-6447.
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
No — it is not registered as an open-access journal in DOAJ or Scopus.
Nuclear Medicine Seminars has an h-index of 7 and a 2-year mean of 0.26 citations per paper (OpenAlex). Its Scopus CiteScore is 0.2, quartile Q4. On 2-year citations it ranks #291 of 346 Scopus journals in Radiology, Nuclear Medicine and Imaging.
Nuclear Medicine Seminars published 24 papers in 2025; its busiest recent year was 2017 with 46. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 79 research articles (2023–2026), authors are most often from Türkiye (94.9%), Cyprus (0.6%) and United States (0.6%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.